Skip to main content

and
  1. Article

    Open Access

    Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

    Nature Communications 8: Article number: 14864 (2017)); Published: 28 March 2017; Updated: 25 April 2017 The original version of this Article contained a typographical error in the spelling of the author Beifa...

    Kuan-lin Huang, Shunqiang Li, Philipp Mertins, Song Cao in Nature Communications (2017)

  2. Article

    Open Access

    Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

    Recent advances in mass spectrometry (MS) have enabled extensive analysis of cancer proteomes. Here, we employed quantitative proteomics to profile protein expression across 24 breast cancer patient-derived xe...

    Kuan-lin Huang, Shunqiang Li, Philipp Mertins, Song Cao in Nature Communications (2017)

  3. No Access

    Article

    Proteogenomics connects somatic mutations to signalling in breast cancer

    Somatic mutations have been extensively characterized in breast cancer, but the effects of these genetic alterations on the proteomic landscape remain poorly understood. Here we describe quantitative mass-spec...

    Philipp Mertins, D. R. Mani, Kelly V. Ruggles, Michael A. Gillette in Nature (2016)

  4. No Access

    Article

    Integrated proteomic analysis of post-translational modifications by serial enrichment

    A mass spectrometry–based method using serial enrichments of different post-translational modifications (SEPTM) enables high-coverage proteomic analysis of multiple PTMs from a single biological sample.

    Philipp Mertins, Jana W Qiao, **al Patel, Namrata D Udeshi in Nature Methods (2013)